229 related articles for article (PubMed ID: 17069522)
21. "Omics" data and levels of evidence for biomarker discovery.
Ghosh D; Poisson LM
Genomics; 2009 Jan; 93(1):13-6. PubMed ID: 18723089
[TBL] [Abstract][Full Text] [Related]
22. Modeling the fitness of plant morphologies across three levels of complexity.
Watson J; Hanan J; Wiles J
Biosystems; 2008; 94(1-2):182-90. PubMed ID: 18611429
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic drug monitoring of cancer chemotherapy.
Alnaim L
J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
[TBL] [Abstract][Full Text] [Related]
24. A history of cancer chemotherapy.
DeVita VT; Chu E
Cancer Res; 2008 Nov; 68(21):8643-53. PubMed ID: 18974103
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics, multiscale modeling and the IUPS Physiome Project.
Hunter PJ; Crampin EJ; Nielsen PM
Brief Bioinform; 2008 Jul; 9(4):333-43. PubMed ID: 18477639
[TBL] [Abstract][Full Text] [Related]
26. Mathematical modeling in cancer drug discovery.
Wang Z; Deisboeck TS
Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
[TBL] [Abstract][Full Text] [Related]
27. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
28. Multiscale modeling of biomedical, biological, and behavioral systems (Part 1).
White R; Peng G; Demir S
IEEE Eng Med Biol Mag; 2009; 28(2):12-3. PubMed ID: 19349247
[TBL] [Abstract][Full Text] [Related]
29. SysBioMed report: advancing systems biology for medical applications.
Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
Krieg AM
Oncogene; 2008 Jan; 27(2):161-7. PubMed ID: 18176597
[TBL] [Abstract][Full Text] [Related]
31. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
32. Practices and pitfalls of mouse cancer models in drug discovery.
Kung AL
Adv Cancer Res; 2007; 96():191-212. PubMed ID: 17161681
[TBL] [Abstract][Full Text] [Related]
33. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
34. A modeling and simulation framework to support early clinical drug development decisions in oncology.
Bruno R; Lu JF; Sun YN; Claret L
J Clin Pharmacol; 2011 Jan; 51(1):6-8. PubMed ID: 20628172
[No Abstract] [Full Text] [Related]
35. Ultrasound assistant chemotherapy may be a novel modality for solid tumors.
Pan H; Ma X; Li M; Chen J; Jiang H
Med Hypotheses; 2009 Oct; 73(4):526-7. PubMed ID: 19573996
[TBL] [Abstract][Full Text] [Related]
36. A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation.
Clairambault J
IEEE Eng Med Biol Mag; 2008; 27(1):20-4. PubMed ID: 18270046
[No Abstract] [Full Text] [Related]
37. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
Ramos S
Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
[TBL] [Abstract][Full Text] [Related]
38. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer.
Toschi L; Jänne PA
Clin Cancer Res; 2008 Oct; 14(19):5941-6. PubMed ID: 18829470
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of biological systems: role of systems biology in medical research.
Assmus HE; Herwig R; Cho KH; Wolkenhauer O
Expert Rev Mol Diagn; 2006 Nov; 6(6):891-902. PubMed ID: 17140376
[TBL] [Abstract][Full Text] [Related]
40. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
